Skip Navigation

Brain 2006 129(11):2808-2810; doi:10.1093/brain/awl291
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goedert, M.
Right arrow Articles by Spillantini, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goedert, M.
Right arrow Articles by Spillantini, M. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Scientific Commentaries

Frontotemporal lobar degeneration through loss of progranulin function

Michel Goedert1 and Maria Grazia Spillantini2

1 MRC Laboratory of Molecular Biology Cambridge, UK 2 Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge Cambridge, UK

Correspondence to: M. Goedert, MRC Laboratory of Molecular Biology, Cambridge, CB2 2QH, UK E-mail: mg@mrc-lmb.cam.ac.uk

The first 150 words of the full text of this article appear below.

The striking clinical and pathological features of frontotemporal lobar degeneration (FTLD) have attracted much attention ever since Arnold Pick reported the first disease cases and Alois Alzheimer described the characteristic nerve cell inclusions of Pick's disease. We now know that FTLD is a common cause of dementia, especially in the population below the age of 65 (Neary et al., 2005Go). Clinically, it encompasses cases of frontotemporal dementia (FTD), semantic dementia (SD) and primary progressive aphasia (PPA). Of these, FTD is the most common. It is characterized by progressive behavioural and personality disturbances, which evolve gradually into cognitive impairment and dementia. SD is characterized by a loss of conceptual knowledge, whereas in PPA progressive language impairment usually precedes the behavioural symptoms. In some patients, behavioural symptoms are also associated with a parkinsonian syndrome or with motor neuron disease (MND).

Pathologically, FTLD is characterized by the severe degeneration of frontal . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
D. G. Munoz, R. Ros, M. Fatas, F. Bermejo, and J. G. de Yebenes
Progressive Nonfluent Aphasia Associated With a New Mutation V363I in Tau Gene
American Journal of Alzheimer's Disease and Other Dementias, September 1, 2007; 22(4): 294 - 299.
[Abstract] [PDF]